PAL.AU · Palla Pharma Limited

-

Please sign in to comment on PAL.AU

1 Comment

Admin

3 years, 7 months ago

Palla Pharma Limited is currently in a long term downtrend where the price is trading 36.1% below its 200 day moving average.

From a valuation standpoint, the stock is 57.3% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 2.9.

Palla Pharma Limited's total revenue sank by 64.4% to $10M since the same quarter in the previous year.

Its net income has dropped by 623.9% to $-26M since the same quarter in the previous year.

Finally, its free cash flow fell by 23.3% to $-5M since the same quarter in the previous year.

Based on the above factors, Palla Pharma Limited gets an overall score of 1/5.

ISIN	AU0000049462
CurrencyCode	AUD
Exchange	AU
Industry	Life Sciences Tools & Services
Sector	Healthcare

Beta	1.07
Market Cap	48M
Dividend Yield	0.0%
Target Price	1.02
PE Ratio	None

ABOUT

Palla Pharma Limited

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

PAL.AU · Palla Pharma Limited

-

Palla Pharma Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Palla Pharma Limited using a moving average strategy